Literature DB >> 7578402

Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.

R G Crystal1, A Mastrangeli, A Sanders, J Cooke, T King, F Gilbert, C Henschke, W Pascal, J Herena, B G Harvey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7578402     DOI： 10.1089/hum.1995.6.5-667

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  7 in total

1.  Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer.

Authors:  E J Kremer; S Boutin; M Chillon; O Danos
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

3.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

4.  Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.

Authors:  B G Harvey; N R Hackett; T El-Sawy; T K Rosengart; E A Hirschowitz; M D Lieberman; M L Lesser; R G Crystal
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 5.  Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.

Authors:  T M Clay; M C Custer; P J Spiess; M I Nishimura
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 6.  A gene therapy approach to treatment of autoimmune disease.

Authors:  C M Seroogy; C G Fathman
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

7.  Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors.

Authors:  Hong Xin; Ruowen Sun; Masahiko Kanehira; Takenori Takahata; Jugoh Itoh; Hiroyuki Mizuguchi; Yasuo Saijo
Journal:  Mol Med       Date:  2009-06-18       Impact factor: 6.354
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.